Expect near-term selling pressure as Streeterville likely exercises warrants and may sell shares. Monitor for an S-1 sticker update reflecting the new exercise price. The 90-day termination clause introduces uncertainty—if the stock rallies, the company might cancel the amendment, but the risk of dilution remains high.
Price Chart
Executive Summary
20/20 Biolabs amended outstanding warrants with Streeterville Capital to reduce the exercise price from $8.00/$11.42 to $2.25 per share, covering approximately 3.63 million shares. This deep cut signals the company is incentivizing exercise to raise capital, which will cause significant dilution and likely pressure the stock price.
Key Facts
- Exercise price of three warrants reduced to $2.25 per share from $8.00/$11.42
- Warrants cover 3,502,627 shares (PPP warrant) plus 62,500 each (two debt warrants) = ~3.63M shares
- Company may terminate amendment after 90 days with 2 trading days' notice
- Streeterville can exercise during the notice period
- No cash consideration was paid for this amendment
Financial Impact
Potential proceeds of ~$8.16M if all warrants exercised at $2.25, implying ~22.7% dilution based on $16M market cap
Risk Factors
- Substantial dilution from warrant exercise
- Potential stock overhang if Streeterville sells converted shares
- Signals financial weakness or need for capital
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-048257 |
| Document: ea028793301ex4-4.htm | 0001213900-26-048257 |
| Document: 0001213900-26-048257-index-headers.html | 0001213900-26-048257 |
| Document: 0001213900-26-048257-index.html | 0001213900-26-048257 |
| Document: 0001213900-26-048257.txt | 0001213900-26-048257 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | DEFA14A | $0.2507 | awaiting T+5 | — | $0.2356 (−6.02%) |
Oct 21, 2026 4d ago | DEF 14A | $0.2507 | awaiting T+5 | — | $0.2356 (−6.02%) |
Aug 17, 2026 9w ago | 8-K | $0.5200 $0.5282 | ▲ +1.58% | ▲ +1.78% | $0.2356 (−54.69%) |
Aug 17, 2026 10w ago | Press Release | $0.5503 $0.5182 | ▼ −5.83% | ▼ −4.64% | $0.2356 (−57.19%) |
Aug 5, 2026 11w ago | 8-K | $0.4413 $0.4610 | ▲ +4.46% | ▲ +4.11% | $0.2356 (−46.61%) |
Jul 1, 2026 16w ago | 8-K | $0.6095 $0.5851 | ▼ −4.00% | ▼ −4.26% | $0.2356 (−61.35%) |
Jun 23, 2026 17w ago | DEFA14A | $0.5669 $0.6095 | ▼ −7.51% | ▼ −5.81% | $0.2356 (+58.44%) |
May 26, 2026 21w ago | 8-K | $0.9700 $0.8400 | ▼ −13.40% | ▼ −13.87% | $0.2356 (−75.71%) |
May 20, 2026 22w ago | 8-K | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2356 (+80.53%) |
May 20, 2026 22w ago | Press Release | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2356 (+80.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers